Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bio Engineering Capital Inc. (BEC) is a venture capital organization established in the 21st century and headquartered in Tokyo, Japan. The firm is dedicated to supporting bioengineering initiatives, particularly in the fields of medical AI, regenerative medicine, and foundational research. BEC's mission is to foster innovation and assist bioengineers in their endeavors, contributing to advancements in healthcare technology.
As of now, BEC aims to support 100 bioengineering entities by the year 2030, reflecting its commitment to driving growth and innovation in the biotech sector. The firm is staffed by a team of experienced professionals with backgrounds in bioengineering and business, ensuring a knowledgeable approach to investment and support.
Bio Engineering Capital Inc. focuses on investments in bioengineering initiatives, with a strong emphasis on medical AI, regenerative medicine, and foundational research. The organization is particularly interested in supporting startups that are innovating within these sectors, aiming to assist 100 bioengineering entities by 2030. This goal highlights BEC's commitment to fostering innovation and growth in critical areas of healthcare technology.
Investments typically target early-stage companies that demonstrate potential for significant impact in the biotech field. BEC seeks to partner with founders who are passionate about advancing medical AI and regenerative medicine, providing not just capital but also strategic support to help them achieve their goals.
Yuki Shimahara, Ph.D. - CEO. Dr. Shimahara has extensive experience in bioengineering and has led various initiatives in the sector.
Mamoru Taniya - Chairperson | Director. Taniya brings a wealth of knowledge in business strategy and governance to the firm.
Shohei Maekawa, MBA - Director. Maekawa has a strong background in investment management and has been involved in numerous successful funding rounds.
Ryota Mori, Ph.D. - Director. Dr. Mori specializes in medical AI and regenerative medicine, contributing valuable insights to BEC's investment strategy.
Founders interested in pitching to Bio Engineering Capital Inc. should submit their proposals through the official website at bioengineering.capital. It is recommended to include a comprehensive business plan and details on how the startup aligns with BEC's investment focus.
What are Bio Engineering Capital Inc.'s investment criteria?
BEC invests in bioengineering initiatives, particularly those focused on medical AI, regenerative medicine, and foundational research. The firm looks for startups that demonstrate innovative approaches and potential for significant impact in these sectors.
How can I pitch to Bio Engineering Capital Inc.?
Founders can pitch their ideas through the official website at bioengineering.capital. It is advisable to include a detailed business plan and information on how the startup aligns with BEC's focus areas.
What makes Bio Engineering Capital Inc. different from other VCs?
BEC's unique focus on bioengineering, particularly in medical AI and regenerative medicine, sets it apart. The firm aims to support a specific number of bioengineering entities by 2030, demonstrating a clear commitment to fostering innovation in these fields.
What is the geographic scope of Bio Engineering Capital Inc.'s investments?
While BEC is based in Tokyo, Japan, it primarily focuses on investments within Asia, particularly in Japan. This geographic focus allows the firm to leverage local expertise and networks in the bioengineering sector.
What kind of support does Bio Engineering Capital Inc. provide to portfolio companies?
BEC offers not only financial support but also strategic guidance and access to a network of bioengineering entities. This support is designed to help startups navigate the challenges of growth and innovation in the biotech field.
What is the typical check size for investments made by Bio Engineering Capital Inc.?
Specific check sizes are not disclosed, but BEC focuses on early-stage investments that align with its mission to support bioengineering initiatives.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.